Adult outcomes of childhood disruptive disorders in offspring of depressed and healthy parents.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 13 08 2018
revised: 03 10 2018
accepted: 05 10 2018
pubmed: 20 10 2018
medline: 26 3 2019
entrez: 20 10 2018
Statut: ppublish

Résumé

Longitudinal studies of children with disruptive disorders (DDs) have shown high rates of antisocial personality disorder (ASPD) and substance use in adulthood, but few have examined the contribution of parental disorders. We examine child-/adulthood outcomes of DDs in offspring, whose biological parents did not have a history of ASPD, bipolar disorder, or substance use disorders. Offspring (N = 267) of parents with or without major depression (MDD), but no ASPD or bipolar disorders were followed longitudinally over 33 years, and associations between DDs and psychiatric and functional outcomes were tested. Eighty-nine (33%) offspring had a DD. Those with, compared to without DDs, had higher rates of MDD (adjusted odds ratio, AOR = 3.42, p < 0.0001), bipolar disorder (AOR = 3.10, p = 0.03), and substance use disorders (AOR = 5.69, p < 0.0001) by age 18, as well as poorer school performance and global functioning. DDs continued to predict MDD and substance use outcomes in adulthood, even after accounting for presence of the corresponding disorder in childhood (MDD: hazards ratio, HR = 3.25, p < 0.0001; SUD, HR = 2.52, p < 0.0001). Associations were similar among the offspring of parents with and without major depression. DDs did not predict adulthood ASPD in either group. Associations are largely accounted for by conduct disorder (CD), as there were few offspring with ADHD, and oppositional defiant disorder (ODD) was not diagnosed at the time this study began. If there is no familial risk for ASPD, bipolar disorder or substance use, childhood DDs do not lead to ASPD in adulthood; however, the children still have poorer prognosis into midlife. Early treatment of children with DD, particularly CD, while carefully considering familial risk for these disorders, may help mitigate later adversity.

Sections du résumé

BACKGROUND
Longitudinal studies of children with disruptive disorders (DDs) have shown high rates of antisocial personality disorder (ASPD) and substance use in adulthood, but few have examined the contribution of parental disorders. We examine child-/adulthood outcomes of DDs in offspring, whose biological parents did not have a history of ASPD, bipolar disorder, or substance use disorders.
METHOD
Offspring (N = 267) of parents with or without major depression (MDD), but no ASPD or bipolar disorders were followed longitudinally over 33 years, and associations between DDs and psychiatric and functional outcomes were tested.
RESULTS
Eighty-nine (33%) offspring had a DD. Those with, compared to without DDs, had higher rates of MDD (adjusted odds ratio, AOR = 3.42, p < 0.0001), bipolar disorder (AOR = 3.10, p = 0.03), and substance use disorders (AOR = 5.69, p < 0.0001) by age 18, as well as poorer school performance and global functioning. DDs continued to predict MDD and substance use outcomes in adulthood, even after accounting for presence of the corresponding disorder in childhood (MDD: hazards ratio, HR = 3.25, p < 0.0001; SUD, HR = 2.52, p < 0.0001). Associations were similar among the offspring of parents with and without major depression. DDs did not predict adulthood ASPD in either group.
LIMITATIONS
Associations are largely accounted for by conduct disorder (CD), as there were few offspring with ADHD, and oppositional defiant disorder (ODD) was not diagnosed at the time this study began.
CONCLUSION
If there is no familial risk for ASPD, bipolar disorder or substance use, childhood DDs do not lead to ASPD in adulthood; however, the children still have poorer prognosis into midlife. Early treatment of children with DD, particularly CD, while carefully considering familial risk for these disorders, may help mitigate later adversity.

Identifiants

pubmed: 30340098
pii: S0165-0327(18)31782-8
doi: 10.1016/j.jad.2018.10.086
pmc: PMC6434691
mid: NIHMS1011565
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-112

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH036197
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH114967
Pays : United States

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Références

Nord J Psychiatry. 2003;57(1):23-8
pubmed: 12745785
Am J Psychiatry. 2005 Oct;162(10):1941-7
pubmed: 16199842
J Atten Disord. 2006 May;9(4):575-81
pubmed: 16648224
Am J Psychiatry. 2006 Jun;163(6):1001-8
pubmed: 16741200
Psychol Med. 2008 Jul;38(7):1057-66
pubmed: 17892623
J Abnorm Psychol. 2009 Feb;118(1):117-30
pubmed: 19222319
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6273-8
pubmed: 19329490
Arch Gen Psychiatry. 2009 Jul;66(7):764-72
pubmed: 19581568
Child Dev. 2010 Jan-Feb;81(1):149-65
pubmed: 20331659
J Abnorm Child Psychol. 2010 Nov;38(8):1139-49
pubmed: 20521096
Am J Psychiatry. 2010 Sep;167(9):1066-74
pubmed: 20634367
Arch Gen Psychiatry. 2012 Dec;69(12):1295-303
pubmed: 23070149
Pediatrics. 2013 Jan;131(1):5-13
pubmed: 23230074
Depress Anxiety. 2013 Jun;30(6):546-53
pubmed: 23424020
J Clin Child Adolesc Psychol. 2014;43(5):777-90
pubmed: 24116918
Clin Neurophysiol. 2014 Apr;125(4):675-684
pubmed: 24140072
Braz J Psychiatry. 2013;35 Suppl 1:S32-9
pubmed: 24142126
Br J Psychiatry. 2014 Jul;205(1):17-23
pubmed: 24764545
J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):360-8.e2
pubmed: 25901772
Am J Psychiatry. 2015 Oct;172(10):967-77
pubmed: 25998281
J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):227-34.e4
pubmed: 26903256
J Clin Psychiatry. 2017 Jan;78(1):90-98
pubmed: 27035627
Am J Psychiatry. 2016 Oct 1;173(10):1024-1032
pubmed: 27113122
JAMA Psychiatry. 2016 Sep 1;73(9):970-7
pubmed: 27532344
J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):841-50
pubmed: 27663939
J Fam Psychol. 2017 Mar;31(2):234-243
pubmed: 27977229
Soc Psychiatry Psychiatr Epidemiol. 2017 Apr;52(4):435-443
pubmed: 28180930
Annu Rev Psychol. 2018 Jan 4;69:383-407
pubmed: 29035692
J Am Acad Child Adolesc Psychiatry. 2018 Jan;57(1):54-60.e4
pubmed: 29301670
J Am Acad Child Adolesc Psychiatry. 1987 Nov;26(6):898-911
pubmed: 3429410
Arch Gen Psychiatry. 1987 Oct;44(10):847-53
pubmed: 3662741
J Psychiatr Res. 1986;20(4):317-25
pubmed: 3806426
Arch Gen Psychiatry. 1982 Aug;39(8):879-83
pubmed: 7103676
J Am Acad Child Psychiatry. 1982 Jul;21(4):392-7
pubmed: 7119313
J Consult Clin Psychol. 1996 Apr;64(2):357-65
pubmed: 8871420
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Arch Gen Psychiatry. 1997 Oct;54(10):932-40
pubmed: 9337774
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
pubmed: 938196

Auteurs

Alexandre Paim Diaz (AP)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States; Postgraduate Program in Health Sciences, University of Southern Santa Catarina (UNISUL), Santa Catarina, Brazil.

Connie Svob (C)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States.

Ruixin Zhao (R)

New York State Psychiatric Institute, New York, United States.

Baxter DiFabrizio (B)

New York State Psychiatric Institute, New York, United States.

Virginia Warner (V)

New York State Psychiatric Institute, New York, United States.

Marc J Gameroff (MJ)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States.

Jamie Skipper (J)

New York State Psychiatric Institute, New York, United States.

Jay Gingrich (J)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States; Sackler Institute for Developmental Psychobiology, Columbia University, New York, United States.

Jonathan Posner (J)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States.

Priya J Wickramaratne (PJ)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; Mailman School of Public Health, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States.

Myrna M Weissman (MM)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; Mailman School of Public Health, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States; Sackler Institute for Developmental Psychobiology, Columbia University, New York, United States.

Ardesheer Talati (A)

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, United States; New York State Psychiatric Institute, New York, United States; Sackler Institute for Developmental Psychobiology, Columbia University, New York, United States. Electronic address: adi.talati@nyspi.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH